RedChip Companies

🌐 OwlTing Group (Nasdaq: OWLS): $5B+ Payment Volume Pipeline Signals a Breakout Moment OwlTing Group is entering 2026 with serious momentum after signing 20+ enterprise clients to OwlPay Harbor in Q1 alone, representing more than $5 billion in annual payment volume across those clients’ existing businesses. These are not small pilot wins either, the client mix spans fintech, remittance, nonprofit, and cross-border B2B payments, with reach across the U.S., Latin America, Africa, the Middle East, and Asia-Pacific. 💡 For investors watching fintech infrastructure stories, this is the kind of enterprise adoption milestone that can start turning platform buildout into recurring transaction revenue. 🔗 Read the full announcement: https://lnkd.in/ew9t2psW TechCrunch Cryptopolitan #OWLS #Fintech #Payments #CrossBorderPayments #SmallCapStocks #Investing

⛏️ Foremost Clean Energy (Nasdaq: FMST | CSE: FAT): Closes C$5.7M Bought Deal to Advance Uranium and Lithium Exploration Foremost Clean Energy completed a bought deal private placement for C$5.7M at C$3.40 per unit, led by Canaccord Genuity - Global Capital Markets, which equals ~US$2.48 per unit. That pricing stands out as a major vote of confidence and highlights meaningful upside if the market closes that premium gap. 💡 The financing is specifically tied to flow-through critical mineral mining expenditures, meaning the proceeds are being deployed directly into exploration and value creation in the ground. With funds committed to Canadian exploration expenses through December 31, 2027, Foremost is now better positioned to accelerate drilling, advance priority targets, and unlock the upside across its mineral portfolio. 🔗 Read the full announcement: https://lnkd.in/e64_7YSA S&P Global Energy Breaking Defense MINING.COM The Northern Miner #FMST #UraniumStocks #CriticalMinerals #SmallCapStocks #MiningNews

⛏️ First Phosphate Corp CSE: PHOS – OTCQX: FRSPF – OTCQX-ADR: FPHOY – FSE: KD0: 40,000m Drill Campaign Fuels Major Upside at Bégin-Lamarche First Phosphate has completed its infill drill campaign at Bégin-Lamarche, with results confirming extensive, continuous mineralization across the existing resource horizon and identifying 2 new phosphate intersects in the Northern and Southern Zones. 💡 Key investor takeaways: • Drill program expanded from 30,000m to 40,000m • New mineralized zones discovered east of the existing zone • Full results now being processed to upgrade the geological model in the coming weeks This update meaningfully expands the scale and value of Bégin-Lamarche. More drilling, new phosphate hits, and strong mineral continuity all add to the bullish resource growth story. It also comes at the right time, with North America racing to build a domestic LFP battery supply chain. 🔗 Read the full announcement: https://lnkd.in/ejb8ZN2v S&P Global Energy Breaking Defense MINING.COM The Northern Miner #FRSPF #PHOS #FPHOY #BatteryMaterials #LFPBatteries #MiningStocks

🌎 Jackpot Digital Inc. (OTCQB: JPOTF | TSXV: JJ) Wins Louisiana Gaming Approval, Unlocking High-Value Casino Market Jackpot Digital Inc. has secured manufacturer and supplier permits from the Louisiana Gaming Control Board, clearing the way to supply and service its Jackpot Blitz® dealerless electronic table games across licensed casinos statewide. 💡 Why Investors Are Paying Attention: • Louisiana’s 24 casinos generated about US$2.5B in annual adjusted gross revenue in 2025 • Jackpot Digital already has several planned installations with a leading national casino operator in the state • Louisiana becomes Jackpot’s fourth commercial state-level approval in the U.S., following Michigan, Mississippi, and Maine 🔗 Read the full announcement: https://lnkd.in/eZkgTqvZ Media Play News TechCrunch #JPOTF #JJ #CasinoTech #GamingStocks #SmallCapStocks #Investing #GrowthStocks

🌐 Comprehensive Healthcare Systems (TSXV: CHS | OTCQB: CMHSF): US$20M+ Pipeline Signals Accelerating Commercial Momentum Comprehensive Healthcare Systems reports its active sales pipeline now exceeds US$20M, supported by growing traction across U.S. labor unions, third-party administrators, and self-insured employers. 💡 The update also highlights key execution moves: • Historical pipeline conversion rate of ~25% to 30% • Expanded sales and marketing team • New Head of Customer Support to support retention and scalability • HubSpot-based AI-enabled CRM rollout to improve pipeline visibility and sales execution CHS is building both the pipeline and the infrastructure to pursue larger-scale revenue opportunities in a fragmented healthcare admin market. 🔗 Learn more: https://lnkd.in/eg_rN7rz Genetic Engineering & Biotechnology News PharmaVoice #CMHSF #CHS #SmallCapStocks #SaaS #HealthTech #HealthcareIT #Investing #StockMarket #GrowthStocks

🚤 Off The Hook Yachts (NYSE American: OTH) Reports Record 2025 Results as Q4 Sales and Profit Accelerate Key Highlights: • FY25 revenue grew 21.1% to $119.9M • Boats sold increased 32.7% to a record 426 • Q4 revenue rose 25.2% to $37.3M • Q4 boats sold jumped 62.5% to 117 • Q4 gross profit increased 63.2%, outpacing revenue growth 💡 Why this matters: • Momentum building into 2026: Q4 unit growth and gross profit expansion signal increasing sales velocity and operating leverage • Higher confidence outlook: Management raised 2026 revenue guidance to $150M–$155M, up from $140M–$145M • Platform scaling: Vertically integrated model (brokerage, inventory, financing, services) supports continued growth and margin expansion Notably, this performance was achieved despite a cautious discretionary spending environment, reinforcing the strength of demand in the pre-owned marine market. 🔗 Read the full announcement: https://lnkd.in/e3Mb7NEE TechCrunch #OTH #OffTheHookYachts #SmallCapStocks #Earnings #IPO #GrowthStocks #Investing

🧪 60 Degrees Pharmaceuticals, INC (Nasdaq: SXTP) Reports 65% Revenue Growth as Commercial Momentum Builds 60 Degrees Pharmaceuticals, INC reported FY2025 results with net product revenues rising 65% to $1M, reflecting continued growth in ARAKODA® as the company expands distribution and market access. 💡 Why this matters: • Revenue acceleration: Sales jumped 65% to $1.0M, signaling increasing demand for ARAKODA® as commercialization ramps • Expanding distribution: New partnerships with GoodRx and Runway Health broaden access across 70,000+ pharmacies and travel-focused telehealth channels • Clinical catalysts: All patients in the expanded access study for relapsing babesiosis were cured, with a potential interim data update expected as early as September 2026 • Capital position: ~$4.0M raised through the ATM facility, now fully utilizing current shelf capacity With commercial expansion underway and clinical catalysts ahead, SXTP is positioning for both near-term revenue growth and longer-term pipeline upside. 🔗 Read the full announcement: https://lnkd.in/eciiM2zi Fierce Biotech Genetic Engineering & Biotechnology News PharmaVoice #SXTP #BiotechStocks #Pharma #HealthcareInvesting #Nasdaq #FinancialResults #ClinicalTrials

🚤 Watch our brief investor overview of Off The Hook Yachts (NYSE American: OTH) and how it is scaling a centralized platform in pre-owned boats. Operationally, Off The Hook Yachts' model is built for speed, with ~5x annual inventory turnover, compared with ~1-2x for typical industry players. 👉 Watch our OTH investor brief: https://lnkd.in/esmKRV8i TechCrunch #OTH #SmallCapStocks #GrowthStocks #Yachts #StockMarket

🎥 Exclusive Interview with Processa Pharmaceuticals CEO George Ng Processa Pharmaceuticals (Nasdaq: PCSA) is taking a bold approach to oncology: modifying FDA-approved cancer drugs to create safer, more effective treatments through its Next Generation Cancer (NGC) pipeline. 💡 Why Investors Should Watch: ✅ De-risked Strategy: Building on proven cancer therapies ✅ Streamlined Path: Leveraging a Regulatory Science Approach to fast-track development ✅ Market Opportunity: Targeting multi-billion-dollar oncology markets with improved tolerability for patients 📈 Could Processa be positioned for a major value unlock as its oncology programs advance? 🔗 Watch our full interview now: https://bit.ly/40SyoC2 Genetic Engineering & Biotechnology News PharmaVoice Biotechnology #PCSA #Biotech #RareDiseases #Oncology #FDA #ProjectOptimus #BiotechInvesting

📊 Investors: Get a Quick Look at GT Biopharma (NASDAQ: GTBP) GT Biopharma (NASDAQ: GTBP) is advancing an immune-based NK cell platform in the biotech space, supported by leading research partnerships and a focus on next-gen innovation. If you follow emerging microcap biotech opportunities, our 30-second breakdown is worth a look. 👉 Watch our overview now: https://lnkd.in/e3sdqCA5 PharmaVoice Genetic Engineering & Biotechnology News Biotechnology #GTBP #BiotechStocks #SmallCapInvesting #Investors #NKCells #StockMarketInsights #BiotechInnovation